Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Expression and clinicopathological significance of Mel-18 mRNA in colorectal cancer.

Tao J, Liu YL, Zhang G, Ma YY, Cui BB, Yang YM.

Tumour Biol. 2014 Oct;35(10):9619-25. doi: 10.1007/s13277-014-2220-6. Epub 2014 Jun 27.

PMID:
24964959
2.

Expression and clinicopathological significance of EED, SUZ12 and EZH2 mRNA in colorectal cancer.

Liu YL, Gao X, Jiang Y, Zhang G, Sun ZC, Cui BB, Yang YM.

J Cancer Res Clin Oncol. 2015 Apr;141(4):661-9. doi: 10.1007/s00432-014-1854-5. Epub 2014 Oct 19.

PMID:
25326896
3.

Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.

Yang D, Dai T, Xue L, Liu X, Wu B, Geng J, Mao X, Wang R, Chen L, Chu X.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):13051-8. eCollection 2015.

4.

High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.

Zheng HT, Shi DB, Wang YW, Li XX, Xu Y, Tripathi P, Gu WL, Cai GX, Cai SJ.

Int J Clin Exp Pathol. 2014 May 15;7(6):3174-81. eCollection 2014.

5.

Low expression of Mel-18 predicts poor prognosis in patients with breast cancer.

Guo BH, Zhang X, Zhang HZ, Lin HL, Feng Y, Shao JY, Huang WL, Kung HF, Zeng MS.

Ann Oncol. 2010 Dec;21(12):2361-9. doi: 10.1093/annonc/mdq241. Epub 2010 May 5.

PMID:
20444850
6.

CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.

Sun H, Wang C, Hao M, Sun R, Wang Y, Liu T, Cong X, Liu Y.

Hum Pathol. 2016 Apr;50:101-8. doi: 10.1016/j.humpath.2015.11.008. Epub 2015 Nov 28.

PMID:
26997443
7.

The novel tumor-suppressor Mel-18 in prostate cancer: its functional polymorphism, expression and clinical significance.

Wang W, Yuasa T, Tsuchiya N, Ma Z, Maita S, Narita S, Kumazawa T, Inoue T, Tsuruta H, Horikawa Y, Saito M, Hu W, Ogawa O, Habuchi T.

Int J Cancer. 2009 Dec 15;125(12):2836-43. doi: 10.1002/ijc.24721.

8.

Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.

Wang F, Li P, Feng Y, Hu YL, Liu YF, Guo YB, Jiang XL, Mao QS, Xue WJ.

Hum Pathol. 2017 Apr;62:108-114. doi: 10.1016/j.humpath.2016.12.016. Epub 2016 Dec 30.

PMID:
28041974
9.

Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.

Gao JY, Song BR, Peng JJ, Lu YM.

World J Gastroenterol. 2012 Nov 7;18(41):5965-71. doi: 10.3748/wjg.v18.i41.5965.

10.

Alpha B-crystallin correlates with poor survival in colorectal cancer.

Shi C, He Z, Hou N, Ni Y, Xiong L, Chen P.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):6056-63. eCollection 2014.

11.

Analysis of Mel-18 expression in prostate cancer tissues and correlation with clinicopathologic features.

Wang W, Lin T, Huang J, Hu W, Xu K, Liu J.

Urol Oncol. 2011 May-Jun;29(3):244-51. doi: 10.1016/j.urolonc.2009.02.004. Epub 2009 Apr 22.

PMID:
19395284
12.

High Rab27A expression indicates favorable prognosis in CRC.

Shi C, Yang X, Ni Y, Hou N, Xu L, Zhan F, Zhu H, Xiong L, Chen P.

Diagn Pathol. 2015 Jun 13;10:68. doi: 10.1186/s13000-015-0303-3.

13.

Expression and clinicopathological significance of Mel-18 and Bmi-1 mRNA in gastric carcinoma.

Lu YW, Li J, Guo WJ.

J Exp Clin Cancer Res. 2010 Nov 8;29:143. doi: 10.1186/1756-9966-29-143.

14.

Expression of BMI-1 and Mel-18 in breast tissue--a diagnostic marker in patients with breast cancer.

Riis ML, L├╝ders T, Nesbakken AJ, Vollan HS, Kristensen V, Bukholm IR.

BMC Cancer. 2010 Dec 16;10:686. doi: 10.1186/1471-2407-10-686.

15.

Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer.

Min L, Dong-Xiang S, Xiao-Tong G, Ting G, Xiao-Dong C.

Acta Obstet Gynecol Scand. 2011 Jul;90(7):737-45. doi: 10.1111/j.1600-0412.2011.01102.x. Epub 2011 Mar 29.

PMID:
21309753
16.

Clinical significance of the upregulated osteopontin mRNA expression in human colorectal cancer.

Likui W, Hong W, Shuwen Z.

J Gastrointest Surg. 2010 Jan;14(1):74-81. doi: 10.1007/s11605-009-1035-z. Epub 2009 Sep 18.

PMID:
19763701
17.

LSF expression and its prognostic implication in colorectal cancer.

Jiang H, Du J, Jin J, Qi X, Pu Y, Fei B.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):6024-31. eCollection 2014.

18.

Over-expression of lncRNA DANCR is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer.

Liu Y, Zhang M, Liang L, Li J, Chen YX.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):11480-4. eCollection 2015.

19.

AC133 expression associated with poor prognosis in stage II colorectal cancer.

Ying X, Wu J, Meng X, Zuo Y, Xia Q, Chen J, Feng Y, Liu R, Li L, Huang W.

Med Oncol. 2013 Mar;30(1):356. doi: 10.1007/s12032-012-0356-z. Epub 2013 Jan 16.

PMID:
23322518
20.

Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.

Xi HQ, Zhao P.

J Clin Pathol. 2011 Jun;64(6):498-503. doi: 10.1136/jcp.2010.087213. Epub 2011 Mar 17.

PMID:
21415057

Supplemental Content

Support Center